The percentage of severe COVID-19 patients was much higher in the anti-MDA5 Ab positive group than that in the negative group (88.6% vs 66.9%, P<0.0001, χ2 test) (Figure 2A). The gene discussed is IFIH1; the disease is COVID-19.